Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts.
Clin Chem
; 67(1): 70-78, 2021 01 08.
Article
in English
| MEDLINE | ID: covidwho-960509
ABSTRACT
BACKGROUND:
The primary role of the International Federation of Clinical Chemistry (IFCC) Committee on Clinical Application of Cardiac Bio-Markers (C-CB) is to provide educational materials about cardiac biomarker use, emphasizing high-sensitivity cardiac troponin assays. CONTENT This mini-review, regarding high-sensitivity cardiac and point-of-care troponin assays, addresses 1) new IFCC C-CB/AACC Academy laboratory practice recommendations; 2) new and updated concepts from the Fourth Universal Definition of Myocardial Infarction; 3) the role of point-of-care assays in practice and research; 4) regulatory challenges concerning point-of-care assays; e) testing in the COVID-19 world.SUMMARY:
Implementation of high-sensitivity cardiac troponin assays makes a difference now and into the future in clinical practice and research. Providing point-of-care high-sensitivity cardiac troponin assays and optimizing studies to allow clearance of these assays by regulatory agencies, in a timely fashion, may provide improved patient management and outcomes.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Point-of-Care Systems
/
Troponin I
/
Clinical Chemistry Tests
/
Troponin T
/
Myocardial Infarction
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Clin Chem
Journal subject:
Chemistry, Clinical
Year:
2021
Document Type:
Article
Affiliation country:
Clinchem
Similar
MEDLINE
...
LILACS
LIS